These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Price type key:
Federal Supply Schedule (FSS): generally available to all Federal Govt agencies /
'BIG4' prices: VA, DoD, Public Health & Coast Guard only /
National Contracts (NC): Available to specific agencies
71085-0003 Market Analysis and Financial Projection
Based on the search results, I can provide the following market analysis and price projections for the drug with NDC 71085-0003:
Product Details
NDC: 71085-0003
Drug Name: Diclofenac sodium
Manufacturer: IPG PHARMACEUTICALS, INC.
Dosage Form: Gel
Strength: 3%
Market Analysis
Generic Status: Diclofenac sodium 3% gel is a generic product, which typically faces more competition and price pressure compared to brand-name drugs.
Manufacturer: IPG PHARMACEUTICALS, INC. is the manufacturer, but they are not one of the major pharmaceutical companies. This may impact their market share and pricing power.
Therapeutic Category: Diclofenac sodium is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. This is a competitive therapeutic area with multiple generic options available.
Formulation: The gel formulation may provide some differentiation compared to oral diclofenac products, potentially supporting slightly higher pricing.
Market Competition: As a generic topical NSAID, this product likely faces significant competition from other manufacturers offering similar products.
Price Projections
While specific pricing data for this NDC is not provided in the search results, I can offer some general projections based on typical generic drug pricing trends:
Annual Price Erosion: Generic drugs typically experience price erosion of 3-5% per year due to competition[3]. For NDC 71085-0003, we can expect similar annual price decreases.
5-Year Pricing Scenario:
Year 1 (Current): 100% of base price
Year 2: 95-97% of base price
Year 3: 90-94% of base price
Year 4: 86-91% of base price
Year 5: 82-88% of base price
Factors Influencing Future Pricing:
New market entrants could accelerate price erosion
Changes in manufacturing costs may impact pricing
Regulatory changes, especially those aimed at drug pricing, could affect the market
Shifts in treatment guidelines for pain management could impact demand
Reimbursement Considerations: As a generic product, this drug is likely to face pressure from payers to keep costs low. Pharmacy benefit managers may prefer lower-cost alternatives, potentially impacting market share and pricing.
Supply Chain Dynamics: The drug's inclusion in the National Drug Code Directory suggests it is part of normal commercial distribution channels[13]. This should support stable supply and pricing, barring any manufacturing or regulatory issues.
Future Outlook
Continued price competition in the generic topical NSAID market is expected
Manufacturers may focus on operational efficiency to maintain profitability despite price erosion
There may be opportunities for product improvements or new delivery methods to differentiate from competitors
Regulatory scrutiny on drug pricing could impact future pricing strategies
In conclusion, NDC 71085-0003 (Diclofenac sodium 3% gel) is likely to face ongoing price pressure due to its status as a generic product in a competitive market. While specific price points are not available, the general trend is expected to be gradual price erosion over time, with potential for more significant decreases if new competitors enter the market or regulatory changes occur.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.